201 related articles for article (PubMed ID: 26967152)
21. Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II.
de Leeuw E; Li C; Zeng P; Li C; Diepeveen-de Buin M; Lu WY; Breukink E; Lu W
FEBS Lett; 2010 Apr; 584(8):1543-8. PubMed ID: 20214904
[TBL] [Abstract][Full Text] [Related]
22. Linear Analogues of the Lipopeptide Battacin With Potent In Vitro Activity Against S. aureus.
Glossop HD; Pearl E; De Zoysa GH; Sarojini V
Adv Protein Chem Struct Biol; 2018; 112():385-394. PubMed ID: 29680242
[TBL] [Abstract][Full Text] [Related]
23. The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate.
Schneider T; Gries K; Josten M; Wiedemann I; Pelzer S; Labischinski H; Sahl HG
Antimicrob Agents Chemother; 2009 Apr; 53(4):1610-8. PubMed ID: 19164139
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides.
De Zoysa GH; Cameron AJ; Hegde VV; Raghothama S; Sarojini V
J Med Chem; 2015 Jan; 58(2):625-39. PubMed ID: 25495219
[TBL] [Abstract][Full Text] [Related]
25. Lipid II and other bactoprenol-bound cell wall precursors as drug targets.
Schneider T; Sahl HG
Curr Opin Investig Drugs; 2010 Feb; 11(2):157-64. PubMed ID: 20112165
[TBL] [Abstract][Full Text] [Related]
26. Tripropeptin C blocks the lipid cycle of cell wall biosynthesis by complex formation with undecaprenyl pyrophosphate.
Hashizume H; Sawa R; Harada S; Igarashi M; Adachi H; Nishimura Y; Nomoto A
Antimicrob Agents Chemother; 2011 Aug; 55(8):3821-8. PubMed ID: 21628543
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of action and limited cross-resistance of new lipopeptide MX-2401.
Rubinchik E; Schneider T; Elliott M; Scott WR; Pan J; Anklin C; Yang H; Dugourd D; Müller A; Gries K; Straus SK; Sahl HG; Hancock RE
Antimicrob Agents Chemother; 2011 Jun; 55(6):2743-54. PubMed ID: 21464247
[TBL] [Abstract][Full Text] [Related]
28. Antibacterial Cyclic Lipopeptide Enamidonins with an Enamide-Linked Acyl Chain from a Streptomyces Species.
Son S; Ko SK; Kim SM; Kim E; Kim GS; Lee B; Ryoo IJ; Kim WG; Lee JS; Hong YS; Jang JH; Ahn JS
J Nat Prod; 2018 Nov; 81(11):2462-2469. PubMed ID: 30339391
[TBL] [Abstract][Full Text] [Related]
29. An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway.
Schneider T; Sahl HG
Int J Med Microbiol; 2010 Feb; 300(2-3):161-9. PubMed ID: 20005776
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antibacterial activity of novel water-soluble nocathiacin analogs.
Xu L; Farthing AK; Dropinski JF; Meinke PT; McCallum C; Hickey E; Liu K
Bioorg Med Chem Lett; 2013 Jan; 23(1):366-9. PubMed ID: 23164707
[TBL] [Abstract][Full Text] [Related]
31. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D
J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121
[TBL] [Abstract][Full Text] [Related]
32. Total synthesis and biological evaluation of the antibiotic lysocin E and its enantiomeric, epimeric, and N-demethylated analogues.
Murai M; Kaji T; Kuranaga T; Hamamoto H; Sekimizu K; Inoue M
Angew Chem Int Ed Engl; 2015 Jan; 54(5):1556-60. PubMed ID: 25504563
[TBL] [Abstract][Full Text] [Related]
33. Lipid II as a target for antibiotics.
Breukink E; de Kruijff B
Nat Rev Drug Discov; 2006 Apr; 5(4):321-32. PubMed ID: 16531990
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity exploration of a small-molecule Lipid II inhibitor.
Fletcher S; Yu W; Huang J; Kwasny SM; Chauhan J; Opperman TJ; MacKerell AD; de Leeuw E
Drug Des Devel Ther; 2015; 9():2383-94. PubMed ID: 25987836
[TBL] [Abstract][Full Text] [Related]
35. Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin.
Zong Y; Sun X; Gao H; Meyer KJ; Lewis K; Rao Y
J Med Chem; 2018 Apr; 61(8):3409-3421. PubMed ID: 29629769
[TBL] [Abstract][Full Text] [Related]
36. Effect of ester to amide or N-methylamide substitution on bacterial membrane depolarization and antibacterial activity of novel cyclic lipopeptides.
Bionda N; Fleeman RM; Shaw LN; Cudic P
ChemMedChem; 2013 Aug; 8(8):1394-402. PubMed ID: 23780744
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and structure-activity relationships of benzophenone-based tetraamides as novel antibacterial agents.
Vooturi SK; Cheung CM; Rybak MJ; Firestine SM
J Med Chem; 2009 Aug; 52(16):5020-31. PubMed ID: 19653650
[TBL] [Abstract][Full Text] [Related]
38. Expanding role of lipid II as a target for lantibiotics.
Martin NI; Breukink E
Future Microbiol; 2007 Oct; 2(5):513-25. PubMed ID: 17927474
[TBL] [Abstract][Full Text] [Related]
39. Natural products to drugs: daptomycin and related lipopeptide antibiotics.
Baltz RH; Miao V; Wrigley SK
Nat Prod Rep; 2005 Dec; 22(6):717-41. PubMed ID: 16311632
[TBL] [Abstract][Full Text] [Related]
40. THCz: Small molecules with antimicrobial activity that block cell wall lipid intermediates.
Reithuber E; Wixe T; Ludwig KC; Müller A; Uvell H; Grein F; Lindgren AEG; Muschiol S; Nannapaneni P; Eriksson A; Schneider T; Normark S; Henriques-Normark B; Almqvist F; Mellroth P
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34785593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
